Feasibility of a Bihormonal Closed-Loop System to Control Postexercise and Postprandial Glucose Excursions
暂无分享,去创建一个
J. Hans DeVries | Joost B. L. Hoekstra | Robin Koops | J. DeVries | J. Hoekstra | A. V. van Bon | Rob Koebrugge | Arianne C. Van Bon | Lisanne D. Jonker | R. Koops | L. Jonker | Rob Koebrugge
[1] W. Kenneth Ward,et al. Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes , 2010, Diabetes Care.
[2] J. Leahy,et al. Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .
[3] Aaron J. Kowalski,et al. Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes. , 2009, Diabetes technology & therapeutics.
[4] Robert G. Sutherlin,et al. A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.
[5] G. Steil,et al. Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.
[6] L. Magni,et al. Multinational Study of Subcutaneous Model-Predictive Closed-Loop Control in Type 1 Diabetes Mellitus: Summary of the Results , 2010, Journal of diabetes science and technology.
[7] M. Seger,et al. Pharmacokinetic and glucodynamic comparisons of recombinant and animal-source glucagon after IV, IM, and SC injection in healthy volunteers. , 1999, Journal of pharmaceutical sciences.
[8] J. Stockman,et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2011 .
[9] J Hans DeVries,et al. Postprandial Glycemic Excursions with the Use of a Closed-Loop Platform in Subjects with Type 1 Diabetes: A Pilot Study , 2010, Journal of diabetes science and technology.